This is consistent with earlier observations that CD180 is more highly expressed in M-CLL (Porakishvili et al. 2005) and positively correlates with CD150 (Gordiienko et al. 2017a), both of which associate with a positive prognostic picture in CLL (Bologna et al. 2016). The gene discussed is SLAMF1; the disease is B-cell chronic lymphocytic leukemia.